RESIDUAL DISEASE
Clinical trials for RESIDUAL DISEASE explained in plain language.
Never miss a new study
Get alerted when new RESIDUAL DISEASE trials appear
Sign up with your email to follow new studies for RESIDUAL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood test trial aims to catch breast Cancer's return before scans can
Disease control Recruiting nowThis study is for people with a high-risk type of breast cancer who have had surgery but still have some cancer cells left. Researchers want to see if a special blood test can find signs that the cancer is coming back before it shows up on standard scans. If the blood test is pos…
Matched conditions: RESIDUAL DISEASE
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 21:56 UTC
-
New drug combo aims to stop aggressive breast cancer from coming back
Disease control Recruiting nowThis study is testing whether adding a copper-lowering drug called tetrathiomolybdate (TM) to standard post-surgery medications can better prevent cancer from spreading or returning in people with high-risk triple-negative breast cancer. It will involve about 204 participants who…
Matched conditions: RESIDUAL DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC